ROS1 Rearrangement
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Lorlatinib Combinations in Lung Cancer (NCT04292119) | Massachusetts General Hospital | 2020-05-01 |
Track ROS1 Rearrangement automatically
Every clearance here is in the API, with alerts when new ones post.